五氧化二钒_MSDS_用途_密度_五氧化二钒CAS号【1314-62-1】

【用途一】
用作分析试剂、催化剂、玻璃用紫外线阻止剂和显影剂

【用途二】
用作制硫酸和有机合成的催化剂，还用于陶瓷、玻璃工业等
【用途三】
用于冶金工业制钒铁合金钢，合成氨工业中脱碳、脱硫和催化剂。用做印染、陶瓷的着色材料，石油化工装置中设备防腐的缓蚀剂，也是制备钒化合物的原料。

[ 密度 ]:
3.357

[ 沸点 ]:
1750ºC

[ 熔点 ]:
690ºC

[ 分子式 ]:
O₅V₂

[ 分子量 ]:
181.880

[ 闪点 ]:
1750ºC

[ 精确质量 ]:
181.862503

[ PSA ]:
77.51000

[ 外观性状 ]:
黄色至生锈-棕色片状

[ 蒸汽压 ]:
8 mm Hg ( 20 °C)

[ 储存条件 ]:
库房通风低温干燥,与酸类,食品分开储运

[ 稳定性 ]:
Stable. Incompatible with chlorine, chlorates, acids, alkali metals, interhalogens.

[ 水溶解性 ]:
H2O: soluble | 1 g/125 mL

详细MSDS(安全技术说明书)

CHEMICAL IDENTIFICATION

RTECS NUMBER :: YW2450000

CHEMICAL NAME :: Vanadium pentoxide (dust)

CAS REGISTRY NUMBER :: 1314-62-1

LAST UPDATED :: 199806

DATA ITEMS CITED :: 55

MOLECULAR FORMULA :: O5-V2

MOLECULAR WEIGHT :: 181.88

WISWESSER LINE NOTATION :: VA2 O5

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: Standard Draize test

ROUTE OF EXPOSURE :: Administration into the eye

SPECIES OBSERVED :: Rodent - rabbit

TYPE OF TEST :: TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Human

DOSE/DURATION :: 346 mg/m3

TOXIC EFFECTS :: Lungs, Thorax, or Respiration - cough Lungs, Thorax, or Respiration - dyspnea Lungs, Thorax, or Respiration - sputum

TYPE OF TEST :: TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Human

DOSE/DURATION :: 1 mg/m3/8H

TOXIC EFFECTS :: Lungs, Thorax, or Respiration - cough Lungs, Thorax, or Respiration - bronchiolar constriction Sense Organs and Special Senses (Eye) - conjunctive irritation

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 10 mg/kg

TOXIC EFFECTS :: Behavioral - coma

TYPE OF TEST :: LC50 - Lethal concentration, 50 percent kill

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 126 mg/m3/6H

TOXIC EFFECTS :: Sense Organs and Special Senses (Eye) - effect, not otherwise specified Behavioral - ataxia Lungs, Thorax, or Respiration - dyspnea

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 12 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 14 mg/kg

TOXIC EFFECTS :: Behavioral - coma

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intratracheal

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 6 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 5 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 23 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 10 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LCLo - Lowest published lethal concentration

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Mammal - cat

DOSE/DURATION :: 500 mg/m3/23M

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Administration onto the skin

SPECIES OBSERVED :: Rodent - rabbit

DOSE/DURATION :: 50 mg/kg

TOXIC EFFECTS :: Liver - other changes Kidney, Ureter, Bladder - other changes

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - guinea pig

DOSE/DURATION :: 20 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 91 mg/kg/26W-I

TOXIC EFFECTS :: Behavioral - alteration of operant conditioning

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 1280 mg/kg/15W-C

TOXIC EFFECTS :: Blood - pigmented or nucleated red blood cells Blood - changes in erythrocyte (RBC) count Skin and Appendages - hair

TYPE OF TEST :: TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 100 ug/m3/24H/24D-C

TOXIC EFFECTS :: Brain and Coverings - recordings from specific areas of CNS Nutritional and Gross Metabolic - weight loss or decreased weight gain Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - phosphatases

TYPE OF TEST :: TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 2 mg/m3/1H/13W-I

TOXIC EFFECTS :: Behavioral - alteration of classical conditioning

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 56 mg/kg/14D-I

TOXIC EFFECTS :: Lungs, Thorax, or Respiration - other changes Biochemical - Metabolism (Intermediary) - lipids including transport

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intratracheal

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 7200 ug/kg/1Y-I

TOXIC EFFECTS :: Lungs, Thorax, or Respiration - other changes Lungs, Thorax, or Respiration - changes in lung weight Biochemical - Metabolism (Intermediary) - amino acids (including renal excretion)

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

DOSE :: 90 mg/kg

SEX/DURATION :: female 6-15 day(s) after conception

TOXIC EFFECTS :: Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Effects on Embryo or Fetus - fetal death

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

DOSE :: 180 mg/kg

SEX/DURATION :: female 6-15 day(s) after conception

TOXIC EFFECTS :: Reproductive - Effects on Embryo or Fetus - other effects to embryo

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

DOSE :: 10 mg/kg

SEX/DURATION :: female 6-15 day(s) after conception

TOXIC EFFECTS :: Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Specific Developmental Abnormalities - other developmental abnormalities

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

DOSE :: 10 mg/kg

SEX/DURATION :: female 6-15 day(s) after conception

TOXIC EFFECTS :: Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea) Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

DOSE :: 50 mg/kg

SEX/DURATION :: female 6-15 day(s) after conception

TOXIC EFFECTS :: Reproductive - Specific Developmental Abnormalities - skin and skin appendages Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Specific Developmental Abnormalities - other developmental abnormalities

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

DOSE :: 5 mg/kg

SEX/DURATION :: female 10 day(s) after conception

TOXIC EFFECTS :: Reproductive - Specific Developmental Abnormalities - skin and skin appendages Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Specific Developmental Abnormalities - other developmental abnormalities

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

DOSE :: 85 mg/kg

SEX/DURATION :: female 6-15 day(s) after conception

TOXIC EFFECTS :: Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Specific Developmental Abnormalities - other developmental abnormalities

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

DOSE :: 85 mg/kg

SEX/DURATION :: female 6-15 day(s) after conception

TOXIC EFFECTS :: Reproductive - Effects on Embryo or Fetus - other effects to embryo

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

DOSE :: 170 mg/kg

SEX/DURATION :: male 60 day(s) pre-mating

TOXIC EFFECTS :: Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth) Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

DOSE :: 170 mg/kg

SEX/DURATION :: male 60 day(s) pre-mating

TOXIC EFFECTS :: Reproductive - Paternal Effects - spermatogenesis (incl. genetic material, sperm morphology, motility, and count) Reproductive - Paternal Effects - testes, epididymis, sperm duct Reproductive - Fertility - male fertility index (e.g. # males impregnating females per # males exposed to fertile nonpregnant females)

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intravenous

DOSE :: 10900 mg/kg

SEX/DURATION :: female 8 day(s) after conception

TOXIC EFFECTS :: Reproductive - Specific Developmental Abnormalities - musculoskeletal system

MUTATION DATA

TYPE OF TEST :: Micronucleus test

TEST SYSTEM :: Rodent - hamster Lung

REFERENCE :: MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 321,35,1994 *** REVIEWS *** ACGIH TLV-Not classifiable as a human carcinogen DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 ACGIH TLV-TWA 0.05 mg/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 TOXICOLOGY REVIEW FRMBAZ Farmacia (Bucharest). (Rompresfilatelia, POB 12-201, Bucharest, Romania) V.1- 1953- Volume(issue)/page/year: 21,325,1973 TOXICOLOGY REVIEW 85DHAX "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Volume(issue)/page/year: V,46,1974 *** U.S. STANDARDS AND REGULATIONS *** MSHA STANDARD-air:CL 0.5 mg/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: 3,275,1971 OSHA PEL (Gen Indu):CL 0.5 mg(V2O5)/m3, respirable dust CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1910.1000,1994 OSHA PEL (Construc):CL 0.5 mg(V2O5)/m3, respirable fraction CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1926.55,1994 OSHA PEL (Shipyard):CL 0.5 mg(V2O5)/m3, respirable fraction CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1915.1000,1993 OSHA PEL (Fed Cont):CL 0.5 mg(V2O5)/m3, respirable fraction CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 41,50-204.50,1994 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH RECOMMENDED EXPOSURE LEVEL (REL) : NIOSH REL TO VANADIUM (as V2O5), resp dust/fume-air:CL 0.05 mg/m3/15M REFERENCE : NIOSH* National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. Volume(issue)/page/year: DHHS #92-100,1992 NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 76210 No. of Facilities: 333 (estimated) No. of Industries: 7 No. of Occupations: 12 No. of Employees: 2562 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 76210 No. of Facilities: 67 (estimated) No. of Industries: 6 No. of Occupations: 17 No. of Employees: 4468 (estimated) No. of Female Employees: 541 (estimated)

[ 符号 ]:

GHS05, GHS07, GHS08, GHS09

[ 信号词 ]:
Danger

[ 危害声明 ]:
H302 + H332-H318-H335-H341-H361d-H372-H411

[ 警示性声明 ]:
P201-P261-P273-P280-P305 + P351 + P338 + P310-P501

[ 个人防护装备 ]:
Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges

[ 危害码 (欧洲) ]:
T:Toxic

[ 风险声明 (欧洲) ]:
R20/22;R37;R48/23;R51/53;R63;R68

[ 安全声明 (欧洲) ]:
S36/37-S38-S45-S61

[ 危险品运输编码 ]:
UN 2862

[ WGK德国 ]:
3

[ RTECS号 ]:
YW1355000

[ 包装等级 ]:
III

[ 海关编码 ]:
2825301000

1.直接法钒精粉与纯碱高温焙烧生成偏钒酸钠，加热搅拌下再加入硫酸中和，制得五氧化二钒。 2.间接法钒矿石与氯化钠成球后进行氧化焙烧，得到偏钒酸钠，与盐酸作用生成五氧化二钒粗品，再经氢氧化钠、氯化铵处理得到偏钒酸铵，偏钒酸铵加热至500　℃进行焙烧分解制得五氧化二钒。 3.市售的偏钒酸铵充分提纯之后，装入内挂釉瓷的坩埚内，尽可能在低温(300～330℃)下慢慢加热，使其分解［12,20］。之所以要保持在低温是为了防止氧化物在坩埚釉面上结焦，抑制生成的氨引起的还原反应。但即使如此，还是有一部分氧化物被还原，因此要加热几小时，整个变为红色之后，加少量浓硝酸蒸发至干，使被还原的部分氧化。或者也可以在550℃左右，在氧气流中，加热几小时，使其完全氧化［21］。这样制得的产品为无定形五氧化二钒(深黄色)，将此产品一点一点地装到铂坩埚里，加热熔化(700～800℃),长时间保持在熔融状态之后，冷却固化，得到针状结晶五氧化二钒(深棕色)。无定形和结晶型氧化物的颜色各不相同，受加热温度的影响色调虽也有差别，但通常是带红的黄色粉末。有毒。五氧化二钒的提纯方法：用上述方法制得的五氧化二钒，含有从原料带来的碱，因此要使其转化为三氯一氧化钒VOCl3,再进行水解。即将50mL纯三氯一氧化钒装入滴液漏斗，滴加到150mL浓硝酸中。这时，必须将漏斗的管尖端伸到浓硝酸的液面下。将生成的深色溶液加热浓缩，分离出锈红色沉淀。上层澄清液呈现出透明绿色时，趁热用砂芯玻璃坩埚过滤。用上述方法制得的五氧化二钒，含有从原料带来的碱，因此要使其转化为三氯一氧化钒VOCl3,再进行水解。即将50mL纯三氯一氧化钒装入滴液漏斗，滴加到150mL浓硝酸中。这时，必须将漏斗的管尖端伸到浓硝酸的液面下。将生成的深色溶液加热浓缩，分离出锈红色沉淀。上层澄清液呈现出透明绿色时，趁热用砂芯玻璃坩埚过滤。 4. 将试剂钒酸铵在350～400℃下加热，同时强烈搅拌，当试剂呈现五氧化二矾特有的红色后，再继续灼烧1～2犺，检验样品氧化合格后，研磨成粉状，再灼烧20min，重新检验氧化合格后即得分析纯五氧化二矾： 5. 将研磨成200目以下的工业五氧化二矾以1:5的比例与煤沥青混合，在500kPa压力下，压制成直径10mm，高12mm的圆柱体，在600℃下焦化12mm后，于150℃管式炉（无空气）用CO ₂气流去除混合物中水分2h，然后升温到300-350℃，并通入氯气进行氯化反应：蒸气 VOCl ₃在冷凝器中冷凝，未凝蒸气用氢氧化钠溶液吸收。当不再有VOCl ₃ 冷凝后，将冷凝液进行蒸馏，（ VOCl ₃沸点为127℃），为除去能带走杂质的颗粒，将占最初液体量2%～5%的剩余物作为残渣留在蒸馏器内。然后将VOCl ₃ 用水水解，并再用过量的20%的氨水处理：所得溶液与析出的结晶一起蒸发至干，最后在500～600℃下灼烧，得到较纯的五氧化二矾：

[ 海关编码 ]: 2825301000

Uniform and well-dispersed YbVO4 hierarchical nanoarchitectures: synthesis and luminescence properties.

J. Nanosci. Nanotechnol. 13(1) , 344-50, (2013)

The YbVO4 micro-doughnuts were successfully fabricated by a facile hydrothermal method. X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR) spectra, scanning electron microscopy (...

Transition metal oxides for organic electronics: energetics, device physics and applications.

Adv. Mater. 24(40) , 5408-27, (2012)

During the last few years, transition metal oxides (TMO) such as molybdenum tri-oxide (MoO(3) ), vanadium pent-oxide (V(2) O(5) ) or tungsten tri-oxide (WO(3) ) have been extensively studied because o...

Low-temperature solution-processed hydrogen molybdenum and vanadium bronzes for an efficient hole-transport layer in organic electronics.

Adv. Mater. 25(14) , 2051-5, (2013)

A simple one-step method is reported to synthesize low-temperature solution-processed transition metal oxides (TMOs) of molybdenum oxide and vanadium oxide with oxygen vacancies for a good hole-transp...

更多文献

公司名：上海化源世纪贸易有限公司

区域：上海市普陀区

价格：

联系人：徐经理

产品详情：五氧化二钒

公司名：上海吉至生化科技有限公司

区域：上海市奉贤区

价格：
￥438.0/25g ￥158.0/5g

联系人：刘佳

产品详情：五氧钒

公司名：上海阿拉丁生化科技股份有限公司

区域：上海市浦东新区

价格：
￥399.0/500g ￥69.0/25g ￥109.0/100g ￥需询单/1g

联系人：阿拉丁

产品详情：五氧化二钒

查看所有供应商请点击：

五氧化二钒供应商

五氧化二钒

五氧化二钒用途

五氧化二钒名称

五氧化二钒物理化学性质